| P2.08 EMERGENCE OF KRAS MUTATIONS AND ACQUIRED RESISTANCE TO ANTI EGFR THERAPY IN COLORECTAL CANCER S Misale, R Yaeger, S Hobor, E Scala, M Janakiraman, D Liska, E Valtorta, ... Annals of Oncology 23 (suppl 5), v23-v32, 2012 | 2020* | 2012 |
| RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF (V600E) PI Poulikakos, Y Persaud, M Janakiraman, X Kong, C Ng, G Moriceau, ... Nature 480 (7377), 387-390, 2011 | 1626 | 2011 |
| Genome sequencing identifies a basis for everolimus sensitivity G Iyer, AJ Hanrahan, MI Milowsky, H Al-Ahmadie, SN Scott, ... Science 338 (6104), 221-221, 2012 | 718 | 2012 |
| Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1 JC Ricarte-Filho, M Ryder, DA Chitale, M Rivera, A Heguy, M Ladanyi, ... Cancer research 69 (11), 4885-4893, 2009 | 640 | 2009 |
| Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies S Veeriah, BS Taylor, S Meng, F Fang, E Yilmaz, I Vivanco, ... Nature genetics 42 (1), 77-82, 2010 | 414 | 2010 |
| Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer G Iyer, H Al-Ahmadie, N Schultz, AJ Hanrahan, I Ostrovnaya, AV Balar, ... Journal of Clinical Oncology 31 (25), 3133, 2013 | 327 | 2013 |
| Genomic and biological characterization of exon 4 KRAS mutations in human cancer M Janakiraman, E Vakiani, Z Zeng, CA Pratilas, BS Taylor, D Chitale, ... Cancer research 70 (14), 5901-5911, 2010 | 307 | 2010 |
| Comparative genomic analysis of primary versus metastatic colorectal carcinomas E Vakiani, M Janakiraman, R Shen, R Sinha, Z Zeng, J Shia, A Cercek, ... Journal of clinical oncology 30 (24), 2956, 2012 | 306 | 2012 |
| Genetic predictors of MEK dependence in non–small cell lung cancer CA Pratilas, AJ Hanrahan, E Halilovic, Y Persaud, J Soh, D Chitale, ... Cancer research 68 (22), 9375-9383, 2008 | 275 | 2008 |
| Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600EBRAF F Xing, Y Persaud, CA Pratilas, BS Taylor, M Janakiraman, QB She, ... Oncogene 31 (4), 446-457, 2012 | 231 | 2012 |
| Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia A Zebisch, PB Staber, A Delavar, C Bodner, K Hiden, K Fischereder, ... Cancer research 66 (7), 3401-3408, 2006 | 116 | 2006 |
| Somatic mutation of fibroblast growth factor receptor‐3 (FGFR3) defines a distinct morphological subtype of high‐grade urothelial carcinoma HA Al‐Ahmadie, G Iyer, M Janakiraman, O Lin, A Heguy, SK Tickoo, ... The Journal of pathology 224 (2), 270-279, 2011 | 88 | 2011 |
| Survival Signaling by C-RAF: Mitochondrial Reactive Oxygen Species and Ca2+ Are Critical Targets AV Kuznetsov, J Smigelskaite, C Doblander, M Janakiraman, M Hermann, ... Molecular and Cellular Biology 28 (7), 2304-2313, 2008 | 55 | 2008 |
| Stress kinase signaling in cancer: fact or fiction? U Rennefahrt, M Janakiraman, R Öllinger, J Troppmair Cancer letters 217 (1), 1-9, 2005 | 51 | 2005 |
| Regulating cell survival by controlling cellular energy production: novel functions for ancient signaling pathways? AV Kuznetsov, M Janakiraman, R Margreiter, J Troppmair FEBS letters 577 (1-2), 1-4, 2004 | 35 | 2004 |
| Marketing mix in the context of library & information products & services M Janakiraman DESIDOC Journal of Library & Information Technology 18 (3), 1998 | 22 | 1998 |
| Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro. RK Swamy, J Manickam, JS Adhikari, BS Dwarakanath Indian journal of experimental biology 43 (8), 686, 2005 | 21 | 2005 |
| Assessment of land degradation and its impacts on land resources of Sivagangai block, Tamil Nadu, India A Natarajan, M Janakiraman, S Manoharan, KS Anil Kumar, S Vadivelu, ... Land degradation and desertification: assessment, mitigation and remediation …, 2010 | 13 | 2010 |
| Corporate environmental management: Imperatives for India M Janakiraman, PD Jose International Workshop on Corporate Environmental Management: Striving …, 2007 | 6 | 2007 |
| Alterations in the PI3K/Akt signaling pathway and association with outcome in invasive high-grade urothelial cancer (UC). AV Balar, G Iyer, H Al-Ahmadie, M Janakiraman, I Ostrovnaya, ... Journal of Clinical Oncology 30 (5_suppl), 277-277, 2012 | 5 | 2012 |
Adriana HeguyNYU School of Medicineכתובת אימייל מאומתת בדומיין nyumc.org
